The global pulmonary function testing device market is likely to reach US$ 167.3 million by 2024. From 2024 to 2034, the market is slated to expand at a moderate CAGR of 4.8% to reach US$ 268.0 million.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | US$ 167.3 million |
| Projected Market Value in 2034 | US$ 268.0 million |
| Value-based CAGR from 2024 to 2034 | 4.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global pulmonary function testing device market rose between 2019 and 2023 at a CAGR of 6.5% to reach US$ 158.1 million. This growth is attributed to the outbreak of the COVID-19 pandemic. Rising respiratory disorders surged the demand for pulmonary testing kits. This exponential rise in demand propelled the subject market growth.
The declined spike in the number of COVID-19 patients decreases the demand for pulmonary function testing devices compared to the historic period. Due to this reduced demand, a fall in the CAGR can be observed.
However, the demand for respiratory assisting devices will increase due to the increasing geriatric population in many countries, such as the United States and the United Kingdom. This shall propel the market in the forecasted period.
Due to government investments, healthcare infrastructure is developing, giving equal importance to respiratory testing devices, propelling the market in the forecasted period. Advancements in technology and integration into traditional testing units will upsurge pulmonary function testing device requirements.
| Historical CAGR from 2019 to 2023 | 6.5% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 4.8% |
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As far as the forecasted market size is concerned, the United States of America outperforms all the other countries to reach US$ 48.4 million by the end of the forecasted period.
The enhancement in the medical infrastructure creates many opportunities for the global pulmonary testing device market. The innovation of products and integration of modern technology, like AI, become easier, thereby driving the market in North America.
Awareness of lung-related diseases has allowed patients worldwide to become more aware of their health, which has helped the market. Rising lung diseases and government inclining toward investment in the medical sector have helped the market to grow.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 5.1% |
| The United Kingdom | 6.0% |
| Japan | 6.4% |
| South Korea | 7.0% |
| China | 5.6% |
This section emphasizes the contribution of different market segments and the marketplace secured by these segments.
Based on product type, handheld devices contribute substantially to the market by blocking 60% of the market. Further, spirometry is the test-type market segment, securing about 46% of the market share among other market segments.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Handheld Devices | 4.6% |
| Spirometry Test | 4.4% |
Handheld pulmonary devices form an important market segment for the global pulmonary function testing device market.
The fundamental reason for this is the portability of devices. These portable devices can control the patient’s health remotely. This remote handling has been leveraging operators’ comfort.
Consequently, this was the largest market shareholding segment, accounting for about 60% of the market. Additionally, the commercialization of these products will lead to sluggish advancement of the said market segment at a CAGR of 4.4% during the forecasted period, which will boost the subject market.
Various key players have been investing more in technological infrastructure. Marketers have focused on R&D to improve instruments for performing different tests and diagnostic techniques. The accuracy of the results gained has also increased drastically, leading to the evolution of spirometers.
Further, integrating artificial intelligence with traditional spirometers has made the new devices more accurate and precise.
Consequently, this results in a substantial market share for the spirometry market segment, which accounts for about 46% of the entire market. The market segment is estimated to advance at a CAGR of 4.4%.
The presence of large-scale organizations clutters the global pulmonary function testing device market. Various organizations have adopted different expansion methods that promote their growth within the market.
Organizations' strategic initiatives to expand in the market include developing new products, research collaborations, forward integration, mergers, partnerships, geographical expansions, and many more.
The reliance of organizations on cutting-edge technology is fueling innovation within the sector. Technological integration has allowed marketers to pivot their products for optimum patient comfort. Some of the important market players include
Key Market Developments
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 167.3 million |
| Projected Market Valuation in 2034 | US$ 268.0 million |
| Value-based CAGR 2024 to 2034 | 4.8% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ million |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The global pulmonary function testing device market shall reach US$ 268.0 million by 2034.
The global pulmonary function testing device market will advance at a moderate CAGR of 4.8%.
Based on device type, handheld devices will lead the market with 60% of the market share based on the device type of test.
Based on test type, spirometry will lead the market with a 46% share.
The global pulmonary function testing device market is expected to reach US$ 167.3 million by 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Handheld
5.3.2. Tabletop
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024 to 2034
6.3.1. Spirometry
6.3.2. Lung Volume Test
6.3.3. Gas Diffusion Test
6.3.4. Exercise Stress Test
6.3.5. High Altitude Simulation Testing
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Test Type, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Test Type, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
7.3.1. Chronic Obstructive Pulmonary Disease
7.3.2. Asthma
7.3.3. Chronic Shortness of Breath
7.3.4. Pulmonary Fibrosis
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2024 to 2034
8.3.1. Hospitals & Clinics
8.3.2. Diagnostic Centres
8.3.3. Homecare Settings
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Test Type
10.2.4. By Application
10.2.5. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Test Type
10.3.4. By Application
10.3.5. By End-User
10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Test Type
11.2.4. By Application
11.2.5. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Test Type
11.3.4. By Application
11.3.5. By End-User
11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Product
12.2.3. By Test Type
12.2.4. By Application
12.2.5. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Test Type
12.3.4. By Application
12.3.5. By End-User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Product
13.2.3. By Test Type
13.2.4. By Application
13.2.5. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Test Type
13.3.4. By Application
13.3.5. By End-User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Product
14.2.3. By Test Type
14.2.4. By Application
14.2.5. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Application
14.3.5. By End-User
14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Product
15.2.3. By Test Type
15.2.4. By Application
15.2.5. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Application
15.3.5. By End-User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product
16.2.3. By Test Type
16.2.4. By Application
16.2.5. By End-User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Test Type
16.3.4. By Application
16.3.5. By End-User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Market Share Analysis, 2023
17.1.1.1. By Product
17.1.1.2. By Test Type
17.1.1.3. By Application
17.1.1.4. By End-User
17.2. Canada
17.2.1. Market Share Analysis, 2023
17.2.1.1. By Product
17.2.1.2. By Test Type
17.2.1.3. By Application
17.2.1.4. By End-User
17.3. Brazil
17.3.1. Market Share Analysis, 2023
17.3.1.1. By Product
17.3.1.2. By Test Type
17.3.1.3. By Application
17.3.1.4. By End-User
17.4. Mexico
17.4.1. Market Share Analysis, 2023
17.4.1.1. By Product
17.4.1.2. By Test Type
17.4.1.3. By Application
17.4.1.4. By End-User
17.5. Germany
17.5.1. Market Share Analysis, 2023
17.5.1.1. By Product
17.5.1.2. By Test Type
17.5.1.3. By Application
17.5.1.4. By End-User
17.6. UK
17.6.1. Market Share Analysis, 2023
17.6.1.1. By Product
17.6.1.2. By Test Type
17.6.1.3. By Application
17.6.1.4. By End-User
17.7. France
17.7.1. Market Share Analysis, 2023
17.7.1.1. By Product
17.7.1.2. By Test Type
17.7.1.3. By Application
17.7.1.4. By End-User
17.8. Spain
17.8.1. Market Share Analysis, 2023
17.8.1.1. By Product
17.8.1.2. By Test Type
17.8.1.3. By Application
17.8.1.4. By End-User
17.9. Italy
17.9.1. Market Share Analysis, 2023
17.9.1.1. By Product
17.9.1.2. By Test Type
17.9.1.3. By Application
17.9.1.4. By End-User
17.10. Poland
17.10.1. Market Share Analysis, 2023
17.10.1.1. By Product
17.10.1.2. By Test Type
17.10.1.3. By Application
17.10.1.4. By End-User
17.11. Russia
17.11.1. Market Share Analysis, 2023
17.11.1.1. By Product
17.11.1.2. By Test Type
17.11.1.3. By Application
17.11.1.4. By End-User
17.12. Czech Republic
17.12.1. Market Share Analysis, 2023
17.12.1.1. By Product
17.12.1.2. By Test Type
17.12.1.3. By Application
17.12.1.4. By End-User
17.13. Romania
17.13.1. Market Share Analysis, 2023
17.13.1.1. By Product
17.13.1.2. By Test Type
17.13.1.3. By Application
17.13.1.4. By End-User
17.14. India
17.14.1. Market Share Analysis, 2023
17.14.1.1. By Product
17.14.1.2. By Test Type
17.14.1.3. By Application
17.14.1.4. By End-User
17.15. Bangladesh
17.15.1. Market Share Analysis, 2023
17.15.1.1. By Product
17.15.1.2. By Test Type
17.15.1.3. By Application
17.15.1.4. By End-User
17.16. Australia
17.16.1. Market Share Analysis, 2023
17.16.1.1. By Product
17.16.1.2. By Test Type
17.16.1.3. By Application
17.16.1.4. By End-User
17.17. New Zealand
17.17.1. Market Share Analysis, 2023
17.17.1.1. By Product
17.17.1.2. By Test Type
17.17.1.3. By Application
17.17.1.4. By End-User
17.18. China
17.18.1. Market Share Analysis, 2023
17.18.1.1. By Product
17.18.1.2. By Test Type
17.18.1.3. By Application
17.18.1.4. By End-User
17.19. Japan
17.19.1. Market Share Analysis, 2023
17.19.1.1. By Product
17.19.1.2. By Test Type
17.19.1.3. By Application
17.19.1.4. By End-User
17.20. South Korea
17.20.1. Market Share Analysis, 2023
17.20.1.1. By Product
17.20.1.2. By Test Type
17.20.1.3. By Application
17.20.1.4. By End-User
17.21. GCC Countries
17.21.1. Market Share Analysis, 2023
17.21.1.1. By Product
17.21.1.2. By Test Type
17.21.1.3. By Application
17.21.1.4. By End-User
17.22. South Africa
17.22.1. Market Share Analysis, 2023
17.22.1.1. By Product
17.22.1.2. By Test Type
17.22.1.3. By Application
17.22.1.4. By End-User
17.23. Israel
17.23.1. Market Share Analysis, 2023
17.23.1.1. By Product
17.23.1.2. By Test Type
17.23.1.3. By Application
17.23.1.4. By End-User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Test Type
18.3.4. By Application
18.3.5. By End-User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Koninklijke Philips N.V
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Minato Holdings Inc
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Medtronic
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Morgan Scientific Inc
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. SCHILLER
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. ndd Medizintechnik AG
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Medical Equipment Europe
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Ganshorn Medizin Electronic
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. CHEST M.I., Inc
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Vyaire Medical, Inc
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Pulmonary Function Testing Device Market
